- Home
- WST vs BR Comparison
WST vs BR Comparison
Compare WST & BR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WST | BR |
|---|---|---|
| Founded | 1923 | 1962 |
| Country | United States | United States |
| Employees | 10800 | N/A |
| Industry | Medical/Dental Instruments | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6B | 17.0B |
| IPO Year | 2004 | 2006 |
Fundamental Metrics
Financial Performance| Metric | WST | BR |
|---|---|---|
| Price | $359.28 | $150.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $325.86 | $246.17 |
| AVG Volume (30 Days) | 682.3K | ★ 1.3M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | 0.30% | ★ 2.43% |
| EPS Growth | 1.49 | ★ 21.16 |
| EPS | 1.92 | ★ 6.18 |
| Revenue | $2,886,900,000.00 | ★ $4,142,600,000.00 |
| Revenue This Year | $6.76 | $10.04 |
| Revenue Next Year | $6.22 | $4.46 |
| P/E Ratio | $188.40 | ★ $24.69 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $208.71 | $133.83 |
| 52 Week High | $367.66 | $271.91 |
Technical Indicators
Market Signals| Indicator | WST | BR |
|---|---|---|
| Relative Strength Index (RSI) | 63.56 | 56.06 |
| Support Level | $349.41 | $149.58 |
| Resistance Level | $367.66 | $160.00 |
| Average True Range (ATR) | 7.69 | 4.22 |
| MACD | -0.97 | 1.30 |
| Stochastic Oscillator | 62.71 | 77.22 |
Price Performance
Historical ComparisonAbout WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About BR Broadridge Financial Solutions Inc.
Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communication and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two operating segments: investor communication solutions and global technology and operations.